nach oben

Erschienen in:

22.04.2019 | Clinical trial

Comparing long-term local recurrence rates of surgical and non-surgical management of close anterior margins in breast conserving surgery

verfasst von: George Boundouki, Joseph Ryan Wong Sik Hee, Natalie Croghan, Katie Stocking, Andrew Pieri, Adam Critchley, Cliona C. Kirwan, James R. Harvey

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

While it is known that histologically involved margins lead to a higher local recurrence rate, re-excision of anterior margins is less common than that of radial margins. However, there are minimal long-term data on the oncological safety of non-surgical management of anterior margins.

Patients and methods

A retrospective study was performed of all patients who underwent breast conserving surgery for breast cancer between 2000 and 2008 at two tertiary referral centres. A close margin was defined as disease within two mm of the resection margin (including disease at the margin).

Results

6922 patients underwent surgery for invasive or in situ breast cancer of whom 277 patients had a close anterior margin alone after breast conserving surgery. Two hundred and twenty patients had non-surgical management of their margins, while 57 had re-excision surgery. Overall, there were 4/57 local recurrences in the surgical management group and 12/220 in the non-surgical management group. The local recurrence-free survival rate at 5 years was 98.2% (1 recurrence, 95% CI 87.8–99.7) in the surgical management group and 97.2% (6 recurrences, 95% CI 93.8–98.7) in the non-surgical management group. At 10 years, the rates were 92.2% (4 recurrences, 95% CI 80.3–97.0) in the surgical management group and 93.9% (12 recurrences, 95% CI 89.4–96.5) in the non-surgical management group. There was no significant difference found in the local recurrence rate between management groups (HR 1.24, 95% CI 0.40, 3.85; p = 0.71).

Conclusions

Local recurrence rates are acceptable and similar in both the surgically and non-surgically managed groups. Non-surgical management of close anterior margins appears oncologically safe when combined with appropriate adjuvant therapy.

Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. https://doi.org/10.1016/j.ejca.2018.07.005 CrossRefPubMedPubMedCentral

Association of Breast Surgery at B (2009) Surgical guidelines for the management of breast cancer. Eur J Surg Oncol 35(Suppl 1):1–22. https://doi.org/10.1016/j.ejso.2009.01.008 CrossRef

Arriagada R, Le MG, Rochard F, Contesso G (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 14(5):1558–1564CrossRefPubMed

Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241. https://doi.org/10.1056/NEJMoa022152 CrossRefPubMed

van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Tong D, Winter J et al (1992) Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A(4–5):801–805CrossRefPubMed

McIntosh A, Freedman G, Eisenberg D, Anderson P (2007) Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer. Am J Clin Oncol 30(2):146–151. https://doi.org/10.1097/01.coc.0000251357.45879.7f CrossRefPubMed

Biglia N, Ponzone R, Bounous VE, Mariani LL, Maggiorotto F, Benevelli C, Liberale V, Ottino MC, Sismondi P (2014) Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery. Breast 23(6):870–875. https://doi.org/10.1016/j.breast.2014.09.009 CrossRefPubMed

Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, Zackrisson S, Cardoso F, Committee EG (2015) Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v8–30. https://doi.org/10.1093/annonc/mdv298 CrossRefPubMed

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, Breast Cancer Trialists’ Collaborative G (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106. https://doi.org/10.1016/S0140-6736(05)67887-7 CrossRefPubMed

10.

Houssami N, Macaskill P, Marinovich ML, Dixon JM, Irwig L, Brennan ME, Solin LJ (2010) Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 46(18):3219–3232. https://doi.org/10.1016/j.ejca.2010.07.043 CrossRefPubMed

11.

Kouzminova NB, Aggarwal S, Aggarwal A, Allo MD, Lin AY (2009) Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer. Am J Surg 198(6):771–780. https://doi.org/10.1016/j.amjsurg.2009.05.027 CrossRefPubMed

12.

Smitt MC, Nowels K, Carlson RW, Jeffrey SS (2003) Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 57(4):979–985CrossRefPubMed

13.

Yoon TI, Lee JW, Lee SB, Sohn G, Kim J, Chung IY, Kim HJ, Ko BS, Son BH, Gong G, Kim SB, Kim SS, Ahn SD, Chung M, Ahn SH (2018) No association of positive superficial and/or deep margins with local recurrence in invasive breast cancer treated with breast-conserving surgery. Cancer Res Treat 50(1):275–282. https://doi.org/10.4143/crt.2017.041 CrossRefPubMed

14.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L (1999) Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44(5):1005–1015CrossRefPubMed

15.

Groot G, Rees H, Pahwa P, Kanagaratnam S, Kinloch M (2011) Predicting local recurrence following breast-conserving therapy for early stage breast cancer: the significance of a narrow (≤ 2 mm) surgical resection margin. J Surg Oncol 103(3):212–216. https://doi.org/10.1002/jso.21826 CrossRefPubMed

16.

Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ (2000) Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18(8):1668–1675CrossRefPubMed

17.

Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, Goffinet DR (1995) The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76(2):259–267CrossRefPubMed

18.

Dunne C, Burke JP, Morrow M, Kell MR (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27(10):1615–1620. https://doi.org/10.1200/JCO.2008.17.5182 CrossRefPubMed

19.

Kestin LL, Goldstein NS, Lacerna MD, Balasubramaniam M, Martinez AA, Rebner M, Pettinga J, Frazier RC, Vicini FA (2000) Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer 88(3):596–607CrossRefPubMed

20.

Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R (2005) Defining negative margins in DCIS patients treated with breast conservation therapy: the University of Chicago experience. Breast J 11(4):242–247. https://doi.org/10.1111/j.1075-122X.2005.21617.x CrossRefPubMed

21.

Vicini FA, Kestin LL, Goldstein NS, Baglan KL, Pettinga JE, Martinez AA (2001) Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in situ treated with breast-conserving therapy. J Surg Oncol 76(4):245–254CrossRefPubMed

22.

Wang SY, Chu H, Shamliyan T, Jalal H, Kuntz KM, Kane RL, Virnig BA (2012) Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst 104(7):507–516. https://doi.org/10.1093/jnci/djs142 CrossRefPubMedPubMedCentral

23.

Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, Klimberg S, Chavez-MacGregor M, Freedman G, Houssami N, Johnson PL, Morrow M (2014) Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol 21(3):704–716. https://doi.org/10.1245/s10434-014-3481-4 CrossRefPubMed

24.

Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS (2016) Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol 23(12):3801–3810. https://doi.org/10.1245/s10434-016-5449-z CrossRefPubMedPubMedCentral

25.

Surgery AoB (2015) margin width in breast conservation surgery

26.

Hassani A, Griffith C, Harvey J (2013) Size does matter: high volume breast surgeons accept smaller excision margins for wide local excision—a national survey of the surgical management of wide local excision margins in UK breast cancer patients. Breast 22(5):718–722. https://doi.org/10.1016/j.breast.2012.12.009 CrossRefPubMed

27.

Mullen R, Macaskill EJ, Khalil A, Elseedawy E, Brown DC, Lee AC, Purdie CA, Jordan LB, Thompson AM (2012) Involved anterior margins after breast conserving surgery: is re-excision required? Eur J Surg Oncol 38(4):302–306. https://doi.org/10.1016/j.ejso.2012.01.004 CrossRefPubMed

28.

Dixon JM, Thomas J, Kerr GR, Williams LJ, Dodds C, Kunkler IH, Macaskill EJ (2016) A study of margin width and local recurrence in breast conserving therapy for invasive breast cancer. Eur J Surg Oncol 42(5):657–664. https://doi.org/10.1016/j.ejso.2016.02.008 CrossRefPubMed

29.

Ang SC, Tapia G, Davidson EJ, Kahramangil B, Mak C, Carmalt H, Warrier S (2016) Positive anterior margins in breast conserving surgery: does it matter? A systematic review of the literature. Breast 27:105–108. https://doi.org/10.1016/j.breast.2015.12.013 CrossRefPubMed

30.

Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77(11):2267–2274. https://doi.org/10.1002/(SICI)1097-0142(19960601)77:11%3c2267:AID-CNCR30%3e3.0.CO;2-V CrossRef

31.

NICE (2002) Improving outcomes in breast cancer

32.

Ali AN, Vapiwala N, Guo M, Hwang WT, Harris EE, Solin LJ (2011) The impact of re-excision and residual disease on local recurrence after breast conservation treatment for patients with early stage breast cancer. Clin Breast Cancer 11(6):400–405. https://doi.org/10.1016/j.clbc.2011.08.003 CrossRefPubMed

33.

Atkins J, Al Mushawah F, Appleton CM, Cyr AE, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA (2012) Positive margin rates following breast-conserving surgery for stage I–III breast cancer: palpable versus nonpalpable tumors. J Surg Res 177(1):109–115. https://doi.org/10.1016/j.jss.2012.03.045 CrossRefPubMedPubMedCentral

34.

Early Breast Cancer Trialists’ Collaborative G, Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart M, Pritchard K (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379(9814):432–444. https://doi.org/10.1016/s0140-6736(11)61625-5 CrossRef

35.

Perez EA, Romond EH, Suman VJ, Jeong JH, Davidson NE, Geyer CE Jr, Martino S, Mamounas EP, Kaufman PA, Wolmark N (2011) Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31. J Clin Oncol 29(25):3366–3373. https://doi.org/10.1200/JCO.2011.35.0868 CrossRefPubMedPubMedCentral

Titel: Comparing long-term local recurrence rates of surgical and non-surgical management of close anterior margins in breast conserving surgery
verfasst von: George Boundouki
Joseph Ryan Wong Sik Hee
Natalie Croghan
Katie Stocking
Andrew Pieri
Adam Critchley
Cliona C. Kirwan
James R. Harvey
Publikationsdatum: 22.04.2019
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 2/2019
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-019-05242-8

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Comparing long-term local recurrence rates of surgical and non-surgical management of close anterior margins in breast conserving surgery

Abstract

Purpose

Patients and methods

Results

Conclusions

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Patients and methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

Establishing physical activity in breast cancer: self-report versus activity tracker

Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer

Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy

Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case–control analysis

Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie